VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Intertek Group plc vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Intertek Group plc
ITRK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Intertek Group plc's moat claims, evidence, and risks.
View ITRK analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 64 / 100 for Intertek Group plc).
- Segment focus: Intertek Group plc has 5 segments (28.3% in Consumer Products); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Intertek Group plc has 6 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Intertek Group plc
Consumer Products
Consumer products testing, inspection and certification (TIC/ATIC) services
Global
Brands, retailers, manufacturers
Third-party conformity assessment and supply chain QA
28.3%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Intertek Group plc strengths
Sanofi strengths
Segment mix
Intertek Group plc segments
Full profile >Consumer Products
Oligopoly
Corporate Assurance
Competitive
Health and Safety
Competitive
Industry and Infrastructure
Competitive
World of Energy
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.